Reza Hejazi, MD
Internal Medicine · Jacksonville, FLNPI 1598050700
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (45.2%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by AbbVie at 45.6% of the total. Reporting peaked in 2022 at $30,229 and has fallen 97.9% since, to $641 in 2025. Among internal medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 70 payments — averaging $632.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$20K
- Cook Medical LLC$20K
- Sanofi$2K
- Olympus Corporation Of The Americas$1K
- Johnson & Johnson$507
- Boston Scientific$174
- plus $392 from 9 others
Across 13 payments — averaging $26,345 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bristol Myers Squibb$340K
- E.r. Squibb & Sons, L.L.C.$2K
What the payments were for
- Consulting fees$1,8424%
- Speaking & faculty fees$19,50044%
- Grants$20,00045%
- Travel & lodging$1,1383%
- Food & beverage$1,3933%
- Education$3771%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 25 | $20,196 |
| Cook Medical LLC | 1 | $20,000 |
| Sanofi | 2 | $1,863 |
| Olympus Corporation Of The Americas | 14 | $1,118 |
| Johnson & Johnson | 11 | $507 |
| Boston Scientific | 2 | $174 |
| Medtronic | 2 | $155 |
| QOL Medical, LLC | 2 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Bristol Myers Squibb | 2 | $31 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $26 |
| Pfizer | 2 | $25 |
| AstraZeneca | 1 | $19 |
| Ironwood Pharmaceuticals, Inc | 1 | $17 |
| Intercept Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Creon$19,843
- DUPIXENT$1,842
- Single Use Electrosurgical Knife KD-655$929
- DISPOSABLE DISTAL ATTACHMENT$929
- Olympus$768
- EndoFlip$140
- SpyGlass Discover$121
How this compares
$44,250 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StelaraUstekinumab | 17 | $464,446 |
| CreonLipase/Protease/Amylase | 13 | $39,596 |
| LinzessLinaclotide | 30 | $31,163 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 58 | $3,937 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 103 | $2,097 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 79 | $1,183 |
| Omeprazole | 73 | $1,144 |
| Esomeprazole Magnesium | 11 | $830 |
| Pantoprazole Sodium | 29 | $375 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 20 | $316 |
| Famotidine | 22 | $292 |
| Lidocaine Hcl ViscousLidocaine Hcl | 14 | $260 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonStelara | $507 | $464,44617 claims |
| AbbVieCreon, Linzess | $20,196 | $70,75843 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,530 internal medicine providers in Florida.
Other internal medicine in Jacksonville
- Daniela Chiriboga SalazarJacksonville$117K
- James PorcelliJacksonville$61K
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Quang NguyenOcala$434K
- Luis Correa LunaSanford$412K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
- Howard FederoffCoconut Grove$302K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.